本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protalix BioTherapeutics Inc

2.78
+0.08002.96%
盘后:2.75-0.0300-1.08%19:44 EDT
成交量:119.89万
成交额:330.04万
市值:2.24亿
市盈率:11.76
高:2.79
开:2.70
低:2.69
收:2.70
52周最高:3.19
52周最低:1.60
股本:8,042.12万
流通股本:7,653.64万
量比:1.29
换手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):0.2364
每股收益(LYR):-0.0841
净资产收益率:31.23%
总资产收益率:15.42%
市净率:3.13
市盈率(LYR):-33.06

数据加载中...

2021/07/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/07

重要事件披露

8-K - Current report
2021/07/02

重要事件披露

8-K - Current report
2021/06/30

重要事件披露

8-K - Current report
2021/06/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/02

重要事件披露

8-K - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

重要事件披露

8-K - Current report
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/28

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

重要事件披露

8-K - Current report
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals